Free Trial
NASDAQ:PDEX

Pro-Dex (PDEX) Stock Price, News & Analysis

Pro-Dex logo
$26.08 +0.44 (+1.72%)
Closing price 10/21/2025 04:00 PM Eastern
Extended Trading
$26.08 0.00 (-0.02%)
As of 10/21/2025 07:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Pro-Dex Stock (NASDAQ:PDEX)

Advanced

Key Stats

Today's Range
$25.31
$26.50
50-Day Range
$23.91
$48.00
52-Week Range
$23.47
$70.26
Volume
34,825 shs
Average Volume
71,764 shs
Market Capitalization
$85.54 million
P/E Ratio
9.66
Dividend Yield
N/A
Price Target
$56.00
Consensus Rating
Moderate Buy

Company Overview

Pro-Dex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

PDEX MarketRank™: 

Pro-Dex scored higher than 53% of companies evaluated by MarketBeat, and ranked 503rd out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Pro-Dex has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Upside Potential

    Pro-Dex has a consensus price target of $56.00, representing about 114.7% upside from its current price of $26.08.

  • Amount of Analyst Coverage

    Pro-Dex has only been the subject of 1 research reports in the past 90 days.

  • Read more about Pro-Dex's stock forecast and price target.
  • Earnings Growth

    Earnings for Pro-Dex are expected to grow by 3.00% in the coming year, from $2.00 to $2.06 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pro-Dex is 9.66, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 43.24.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pro-Dex is 9.66, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.14.

  • Price to Book Value per Share Ratio

    Pro-Dex has a P/B Ratio of 2.32. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Pro-Dex's valuation and earnings.
  • Percentage of Shares Shorted

    12.59% of the float of Pro-Dex has been sold short.
  • Short Interest Ratio / Days to Cover

    Pro-Dex has a short interest ratio ("days to cover") of 6.6.
  • Change versus previous month

    Short interest in Pro-Dex has recently increased by 1.39%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Pro-Dex does not currently pay a dividend.

  • Dividend Growth

    Pro-Dex does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.59% of the float of Pro-Dex has been sold short.
  • Short Interest Ratio / Days to Cover

    Pro-Dex has a short interest ratio ("days to cover") of 6.6.
  • Change versus previous month

    Short interest in Pro-Dex has recently increased by 1.39%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Pro-Dex has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • Search Interest

    22 people have searched for PDEX on MarketBeat in the last 30 days. This is an increase of 633% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Pro-Dex to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pro-Dex insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    45.90% of the stock of Pro-Dex is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 15.28% of the stock of Pro-Dex is held by institutions.

  • Read more about Pro-Dex's insider trading history.
Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PDEX Stock News Headlines

Pro-Dex Full Year 2025 Earnings: EPS Misses Expectations
Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
Pro-Dex, Inc. (PDEX) - Yahoo Finance
See More Headlines

PDEX Stock Analysis - Frequently Asked Questions

Pro-Dex's stock was trading at $46.75 at the start of the year. Since then, PDEX shares have decreased by 44.2% and is now trading at $26.08.

Pro-Dex, Inc. (NASDAQ:PDEX) announced its quarterly earnings results on Thursday, September, 4th. The medical instruments supplier reported $0.36 EPS for the quarter, missing analysts' consensus estimates of $0.47 by $0.11. The medical instruments supplier had revenue of $17.49 million for the quarter, compared to analyst estimates of $17.90 million. Pro-Dex had a trailing twelve-month return on equity of 26.67% and a net margin of 13.48%.

Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pro-Dex investors own include NVIDIA (NVDA), Broadcom (AVGO), Novo Nordisk A/S (NVO), Adobe (ADBE), ServiceNow (NOW), Arista Networks (ANET) and Jabil (JBL).

Company Calendar

Last Earnings
9/04/2025
Today
10/21/2025
Next Earnings (Estimated)
10/30/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PDEX
CIK
788920
Employees
140
Year Founded
1975

Price Target and Rating

High Price Target
$56.00
Low Price Target
$56.00
Potential Upside/Downside
+114.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.70
Trailing P/E Ratio
9.66
Forward P/E Ratio
13.04
P/E Growth
N/A
Net Income
$8.98 million
Net Margins
13.48%
Pretax Margin
18.11%
Return on Equity
26.67%
Return on Assets
14.95%

Debt

Debt-to-Equity Ratio
0.25
Current Ratio
3.23
Quick Ratio
1.71

Sales & Book Value

Annual Sales
$66.59 million
Price / Sales
1.28
Cash Flow
$3.12 per share
Price / Cash Flow
8.36
Book Value
$11.23 per share
Price / Book
2.32

Miscellaneous

Outstanding Shares
3,280,000
Free Float
1,774,000
Market Cap
$85.54 million
Optionable
Not Optionable
Beta
-0.11

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for November 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:PDEX) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners